Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ting Martin

Showing results (31-40 of 60) with videos related to

Pageof 6
Sort By:
Advances in Radiation Oncology|December 19, 2022
Experience of Telemedicine Visits in Radiation Oncology During the COVID-19 Pandemic: A US National Survey and Lessons Learned for Incorporating Telemedicine Post-COVID-19Ting Martin Ma, Neil R Parikh, Rebecca G Philipson, et al.
BJU International|February 16, 2023
LUNAR: a randomized Phase 2 study of <sup>177</sup> Lutetium-PSMA Neoadjuvant to Ablative Radiotherapy for Oligorecurrent Prostate Cancer (clinical trial protocol)Ting Martin Ma, Johannes Czernin, Carol Felix, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|March 19, 2023
The role of adaptive planning in margin-reduced, MRI-guided stereotactic body radiotherapy to the prostate bed following radical prostatectomy: Post-hoc analysis of a phase II clinical trialJohn Nikitas, Lauren M Smith, Yu Gao, et al.
BMC Cancer|May 12, 2021
Magnetic resonance imaging-guided stereotactic body radiotherapy for prostate cancer (mirage): a phase iii randomized trialTing Martin Ma, James M Lamb, Maria Casado, et al.
Journal of Applied Clinical Medical Physics|November 7, 2025
A hybrid IGRT workflow using SGRT and CBCT for prostate SBRT: Feasibility, efficiency, and safetyJuergen Meyer, Angelia Tran, Ting Martin Ma, et al.
Prostate Cancer and Prostatic Diseases|August 17, 2021
Radiation therapy dose and androgen deprivation therapy in localized prostate cancer: a meta-regression of 5-year outcomes in phase III randomized controlled trialsTommy Jiang, Daniela Markovic, Jay Patel, et al.
Practical Radiation Oncology|September 3, 2023
Stereotactic Body Radiation Therapy: A Radiosurgery Society Guide to the Treatment of Localized Prostate Cancer Illustrated by Challenging CasesTing Martin Ma, Colton Ladbury, Maxwell Tran, et al.
JAMA Oncology|January 12, 2023
Magnetic Resonance Imaging-Guided vs Computed Tomography-Guided Stereotactic Body Radiotherapy for Prostate Cancer: The MIRAGE Randomized Clinical TrialAmar U Kishan, Ting Martin Ma, James M Lamb, et al.
International Journal of Radiation Oncology, Biology, Physics|October 23, 2023
Impact of Interfractional Bladder and Trigone Displacement and Deformation on Radiation Exposure and Subsequent Acute Genitourinary Toxicity: A Post Hoc Analysis of Patients Treated with Magnetic Resonance Imaging-Guided Prostate Stereotactic Body Radiation Therapy in a Phase 3 Randomized TrialBeth K Neilsen, Ting Martin Ma, Wisdom O Akingbemi, et al.
Cancers|February 25, 2022
A Prospective Phase II Study of Automated Non-Coplanar VMAT for Recurrent Head and Neck Cancer: Initial Report of Feasibility, Safety, and Patient-Reported OutcomesKaley E Woods, Ting Martin Ma, Kiri A Cook, et al.
Pageof 6

Showing results (31-40 of 60) with videos related to

Sort By:
Pageof 6
Advances in Radiation Oncology|December 19, 2022
Experience of Telemedicine Visits in Radiation Oncology During the COVID-19 Pandemic: A US National Survey and Lessons Learned for Incorporating Telemedicine Post-COVID-19Ting Martin Ma, Neil R Parikh, Rebecca G Philipson, et al.
BJU International|February 16, 2023
LUNAR: a randomized Phase 2 study of <sup>177</sup> Lutetium-PSMA Neoadjuvant to Ablative Radiotherapy for Oligorecurrent Prostate Cancer (clinical trial protocol)Ting Martin Ma, Johannes Czernin, Carol Felix, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|March 19, 2023
The role of adaptive planning in margin-reduced, MRI-guided stereotactic body radiotherapy to the prostate bed following radical prostatectomy: Post-hoc analysis of a phase II clinical trialJohn Nikitas, Lauren M Smith, Yu Gao, et al.
BMC Cancer|May 12, 2021
Magnetic resonance imaging-guided stereotactic body radiotherapy for prostate cancer (mirage): a phase iii randomized trialTing Martin Ma, James M Lamb, Maria Casado, et al.
Journal of Applied Clinical Medical Physics|November 7, 2025
A hybrid IGRT workflow using SGRT and CBCT for prostate SBRT: Feasibility, efficiency, and safetyJuergen Meyer, Angelia Tran, Ting Martin Ma, et al.
Prostate Cancer and Prostatic Diseases|August 17, 2021
Radiation therapy dose and androgen deprivation therapy in localized prostate cancer: a meta-regression of 5-year outcomes in phase III randomized controlled trialsTommy Jiang, Daniela Markovic, Jay Patel, et al.
Practical Radiation Oncology|September 3, 2023
Stereotactic Body Radiation Therapy: A Radiosurgery Society Guide to the Treatment of Localized Prostate Cancer Illustrated by Challenging CasesTing Martin Ma, Colton Ladbury, Maxwell Tran, et al.
JAMA Oncology|January 12, 2023
Magnetic Resonance Imaging-Guided vs Computed Tomography-Guided Stereotactic Body Radiotherapy for Prostate Cancer: The MIRAGE Randomized Clinical TrialAmar U Kishan, Ting Martin Ma, James M Lamb, et al.
International Journal of Radiation Oncology, Biology, Physics|October 23, 2023
Impact of Interfractional Bladder and Trigone Displacement and Deformation on Radiation Exposure and Subsequent Acute Genitourinary Toxicity: A Post Hoc Analysis of Patients Treated with Magnetic Resonance Imaging-Guided Prostate Stereotactic Body Radiation Therapy in a Phase 3 Randomized TrialBeth K Neilsen, Ting Martin Ma, Wisdom O Akingbemi, et al.
Cancers|February 25, 2022
A Prospective Phase II Study of Automated Non-Coplanar VMAT for Recurrent Head and Neck Cancer: Initial Report of Feasibility, Safety, and Patient-Reported OutcomesKaley E Woods, Ting Martin Ma, Kiri A Cook, et al.
Pageof 6